506U78 in Treating Patients With Recurrent or Refractory Cutaneous T-cell Lymphoma
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop
growing or die. Phase II trial to study the effectiveness of 506U78 in treating patients who
have recurrent or refractory cutaneous T-cell lymphoma